[FURL=https://www.industryarc.com/Research/Cell-Lysis-Disruption-Market-Research-508483?utm_source=briefingwire&utm_medium=pressrelease&utm_campaign=paidpressrelease]Cell Lysis & Disruption Market[/FURL] size is estimated to reach $6.1 billion by 2026, growing at a CAGR of 8.3% during the forecast period 2021-2026. Cell Lysis & Disruption is a method in which the cell membrane is destroyed to release inter-cellular materials such as deoxyribonucleic acid (DNA), ribonucleic acid (RNA), and proteins from a cell. These methods are an important unit operation for immunoassays for point-of-care diagnostics, down streaming processes, such as protein extraction for studying protein function and structure, drug screening, and mRNA transcriptome determination.Key Takeaways
Geographically, North America Cell Lysis & Disruption Market accounted for the highest revenue share in 2020 and it is poised to dominate over the period 2021-2026 owing to the growing demand for testing of chelating agents using mammalian cells.
The rise in the adoption of ultrasonic homogenization is driving the Physical Disruption segment. However, the high cost of cell-based research is one of the major factors that is said to reduce the growth of the Cell Lysis & Disruption Market.
Detailed analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Cell Lysis & Disruption Market report.
Download Sample Report @ [FURL]https://www.industryarc.com/pdfdownload.php?id=508483[/FURL]
Cell Lysis & Disruption Market Segment Analysis-By Geography
The Cell Lysis & Disruption Market based on the Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and Rest of World. North America held the largest share with 33% of the overall market in 2020. The growth in this segment is owing to the factors such as the increasing demand for sodium dodecyl sulfate (SDS) to provide cell lysis of the order of seconds and the growing demand for testing of chelating agents using mammalian cells.
The rise in the efficiency of reagent-based methods for protein extraction is driving the growth of the Cell Lysis & Disruption Market. Asia-Pacific segment is estimated to be the fastest growing segment over the period 2021-2026. The growth in this segment is owing to the factors such as the rise in the adoption of ultrasonic homogenization, growing demand for osmotic shock technique using bacterial cells, and an increase in the research and development activities for developing advanced products.
Cell Lysis & Disruption Market Drivers
Increase in the Adoption of Mammalian Cells for Lysis and Disruption
Rise in the Demand for Physical Disruption Technique
Cell Lysis & Disruption Market Competitive Landscape:
Key companies of this market are Thermo Fisher Scientific Inc, F. Hoffmann-La Roche Ltd, Merck KGaA, Becton Dickinson & Company (BD), Danaher, Miltenyi Biotec GmbH, Bio-Rad Laboratories, Inc, Qiagen NV, BioVision, Inc and Claremont BioSolutions, LLC among others.
About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.